One‐year sustained glycaemic control and less hypoglycaemia with new insulin glargine 300 U/ml compared with 100 U/ml in people with type 2 diabetes using basal plus meal‐time insulin: the EDITION 1 12‐month randomized trial, including 6‐month extension-Reference-Cited by-同舟云学术

One‐year sustained glycaemic control and less hypoglycaemia with new insulin glargine 300 U/ml compared with 100 U/ml in people with type 2 diabetes using basal plus meal‐time insulin: the EDITION 1 12‐month randomized trial, including 6‐month extension

Published:2015-05-11 Issue:9 Volume:17 Page:835-842
ISSN:1462-8902
Container-title:Diabetes, Obesity and Metabolism
language:en
Short-container-title:Diabetes Obes Metab

Author:

Riddle M. C.¹,Yki‐Järvinen H.²,Bolli G. B.³,Ziemen M.⁴,Muehlen‐Bartmer I.⁴,Cissokho S.⁵,Home P. D.⁶

Affiliation:

1. Department of Medicine, Oregon Health and Science University Portland OR USA

2. Department of Medicine University of Helsinki Helsinki Finland

3. Department of Medicine, Perugia University Medical School Perugia Italy

4. Sanofi‐Aventis Deutschland GmbH Frankfurt am Main Germany

5. Keyrus Biopharma Levallois‐Perret France

6. Department of Medicine, Newcastle University Newcastle upon Tyne UK

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/dom.12472

Reference13 articles.

1. Optimizing the Replacement of Basal Insulin in Type 1 Diabetes Mellitus: No Longer an Elusive Goal in the Post-NPH Era

2. Evolution of Insulin Development: Focus on Key Parameters

3. When oral agents fail: practical barriers to starting insulin

4. Will the next generation of basal insulins offer clinical advantages?

5. New insulin glargine 300 units.mL‐1 provides a more even activity profile and prolonged glycemic control at steady state compared with insulin glargine 100 units.mL‐1;Becker RH;Diabetes Care,2015

Cited by 100 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and safety of insulin glargine 300 U/mL in people with type 2 diabetes in China: The INITIATION study;Diabetes, Obesity and Metabolism;2024-07-29

2. Efficacy and safety of basal insulins in people with type 2 diabetes mellitus: a systematic review and network meta-analysis of randomized clinical trials;Frontiers in Endocrinology;2024-03-21

3. 9. Pharmacologic Approaches to Glycemic Treatment: Standards of Care in Diabetes—2024;Diabetes Care;2023-12-11

4. Clinical impact after implementing an insulin protocol involving a switch to insulin glargine 300 U/ml as basal insulin for inpatient glycaemic control: A retrospective single-centre study;Journal of Diabetes and its Complications;2023-09

5. ONWARDS and upwards for basal insulin;The Lancet;2023-06